Loading clinical trials...
Loading clinical trials...
Liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) and viral hepatitis have the potential to progress to cirrhosis and finally hepatocellular carcinoma (HC...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maastricht University Medical Center
NCT00345930 · Liver Diseases
NCT06613698 · Liver Diseases, Alcoholic
NCT07400289 · Liver Diseases
NCT05264051 · Liver Diseases
NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more
Maastricht University Medical Center, Division of Gastroenterology/Hepatology
Maastricht, Limburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions